Warnings In 2019, AERs In 2009: Touchstones Toward Homeopathic Guidance

Priority enforcement areas listed in draft guidance note delivery formats other than oral and topical, such as nasal gel product that was early alarm in FDA's evaluation of safety and efficacy across homeopathic market. Recent warnings also noted in revised draft.

Guidance word in red keyboard buttons

The Food and Drug Administration tipped its hand about enforcement areas it would prioritize in a revised draft guidance for the homeopathic drug sector when it warned manufacturers and a marketer in May about ophthalmic product quality control and labeling problems.

The priority enforcement areas listed in the draft guidance published 24 October also notes delivery formats other than oral and topical

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation